These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7890234)

  • 21. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
    Brynskov J; Tvede N
    Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
    Van Kemseke C; Belaiche J; Louis E
    Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-8 in inflammatory bowel disease.
    Jones SC; Evans SW; Lobo AJ; Ceska M; Axon AT; Whicher JT
    J Gastroenterol Hepatol; 1993; 8(6):508-12. PubMed ID: 8280836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating interleukin-6 receptor in patients with sepsis syndrome.
    Frieling JT; van Deuren M; Wijdenes J; van der Meer JW; Clement C; van der Linden CJ; Sauerwein RW
    J Infect Dis; 1995 Feb; 171(2):469-72. PubMed ID: 7661926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
    Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
    Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease.
    Proujansky R; Carpenter AB
    J Pediatr Gastroenterol Nutr; 1991 Oct; 13(3):277-84. PubMed ID: 1791504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble interleukin-6 receptor levels in pleural effusions.
    Yokoyama A; Kohno N; Fujino S; Abe M; Ishida O; Hiwada K
    Respir Med; 1996 Jul; 90(6):329-32. PubMed ID: 8759474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease.
    Nielsen OH; Langholz E; Hendel J; Brynskov J
    Dig Dis Sci; 1994 Sep; 39(9):1918-23. PubMed ID: 7521822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
    Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
    J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease.
    Suzuki Y; Saito H; Kasanuki J; Kishimoto T; Tamura Y; Yoshida S
    Life Sci; 1990; 47(24):2193-7. PubMed ID: 2266787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases.
    Doré P; Lelièvre E; Morel F; Brizard A; Fourcin M; Clemént C; Ingrand P; Daneski L; Gascan H; Wijdenes J; Gombert J; Preud'homme JL; Lecron JC
    Clin Exp Immunol; 1997 Jan; 107(1):182-8. PubMed ID: 9010274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.
    Gross V; Andus T; Caesar I; Roth M; Schölmerich J
    Gastroenterology; 1992 Feb; 102(2):514-9. PubMed ID: 1370661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.
    De Benedetti F; Massa M; Pignatti P; Albani S; Novick D; Martini A
    J Clin Invest; 1994 May; 93(5):2114-9. PubMed ID: 8182142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.